Surgical LAA Exclusion: State-of-the-Art

Introduction

This on-demand webcast features the proceedings of an official satellite symposium that occurred during the Heart Valve Society 2022 Scientific Meeting.

Agenda

		Viewing Options: Click on the presentation titles below to view individual segments of the activity, or the Access Button to view the activity in its entirety. Access >>

Agenda

LAAOS III – The Significance to the Practice of Surgical LAA Exclusion
Richard Whitlock, MD, PhD

CHA2DS2-VASc Score and Anticoagulation Following the Cox Maze Procedure. Is there a Need for a Different Scoring System?
Niv Ad, MD

Standalone Epicardial LAA Exclusion for Thromboembolism Prevention in Atrial Fibrillation
Richard Cartledge, MD

Prophylactic Epicardial LAA Exclusion for Thromboembolism Prevention in High-Risk Patients
Basel Ramlawi, MD

Panel Discussion with Q&A Session
Moderator: Niv Ad, MD
Panelists: Richard Cartledge, MD, Basel Ramlawi, MD, Richard Whitlock, MD, PhD

Educational grant support provided by:
AtriCure

Joint Providership
MediaSphere Medical, LLC and Ciné-Med

Faculty

Faculty

Niv Ad, MD
White Oaks Medical Center
University of Maryland
Silver Spring, MD

Basel Ramlawi, MD
Lankenau Heart Institute
Mainline Health System
Philadelphia, PA

Richard Cartledge, MD
Boca Raton Regional Hospital
Boca Raton, FL

Richard Whitlock, MD, PhD
McMaster University Medical School
Hamilton, Canda